PhD defences
-
21 Sept. 2026, 12:30-15:30
Development and Scalable Production of Inactivated HCV and SARS-CoV-2 Vaccines: From Bioprocess Integration to Immunological Ev
-
21 Sept. 2026, 14:00-17:00
Gastrointestinal hormones after intestinal resection and the therapeutic use of the glucagon-like peptide 2 analog, glepaglutid
-
21 Sept. 2026, 15:45-18:45
Modulating the Muscarinic M1 Receptor to Inhibit Drug Seeking Behaviour: A Promising Target in Cocaine Addiction Treatment

